Dermagnostix GmbH

Dermagnostix GmbH develops diagnostic test systems specifically designed to differentiate between psoriasis and eczema. Their portfolio includes a disposable test disk called the PsorX-LabDisk, an automated analyzer called the LabDisk-Analyzer for molecular analysis, and connectivity solutions to streamline integration with laboratory workflows. These devices are tailored for dermatopathologists and dermatologists.

Dermagnostix GmbH is headquartered in Germany. Their devices are registered in the eudamed database, which is the EU’s official registry for medical devices. This listing ensures transparency regarding their authorized products within the European market.

Dermagnostix’s products fall under Class A and In Vitro Diagnostic (IVD) General classifications. Class A devices are typically low-risk, while IVD General classification applies to diagnostic tests that do not pose significant health risks but still require regulatory oversight. These classifications help determine the regulatory requirements for their development, manufacturing, and market placement.

The LabDisk-Analyzer automates molecular analysis for the PsorX-LabDisk, enabling faster and more precise differentiation between psoriasis and eczema. The connectivity solutions bridge these systems with laboratory information management software, improving workflow efficiency and data integration. Together, they enhance diagnostic accuracy and operational streamlining for healthcare providers.